umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson's disease
Show others and affiliations
2017 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 12, no 9, article id e0184117Article in journal (Refereed) Published
Abstract [en]

Alpha-synuclein (aS) amyloid formation is involved in Parkinson's disease (PD); therefore, small molecules that target aS and affect its aggregation are of interest as future drug candidates. We recently reported modified ring-fused 2-pyridones that modulate aS amyloid formation in vitro. Here, we describe the effects of such molecules on behavioral parameters of a Drosophila model of PD (i.e., flies expressing human aS), using a new approach (implemented in a commercially available FlyTracker system) to quantify fly mobility. FlyTracker allows for automated analysis of walking and climbing locomotor behavior, as it collects large sequences of data over time in an unbiased manner. We found that the molecules per se have no toxic or kinetic effects on normal flies. Feeding aS-expressing flies with the amyloid-promoting molecule FN075, remarkably, resulted in increased fly mobility at early time points; however, this effect switched to reduced mobility at later time points, and flies had shorter life spans than controls. In contrast, an amyloid inhibitor increased both fly kinetics and life span. In agreement with increased aS amyloid formation, the FN075-fed flies had less soluble aS, and in vitro aS-FN075 interactions stimulated aS amyloid formation. In addition to a new quantitative approach to probe mobility (available in FlyTracker), our results imply that aS regulates brain activity such that initial removal (here, by FN075-triggered assembly of aS) allows for increased fly mobility.

Place, publisher, year, edition, pages
2017. Vol. 12, no 9, article id e0184117
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:umu:diva-139797DOI: 10.1371/journal.pone.0184117ISI: 000408816900026PubMedID: 28863169OAI: oai:DiVA.org:umu-139797DiVA, id: diva2:1145002
Available from: 2017-09-27 Created: 2017-09-27 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

fulltext(4852 kB)82 downloads
File information
File name FULLTEXT01.pdfFile size 4852 kBChecksum SHA-512
21caebf36e13b2f5324a0fa01362f1a79f4bae02540826a48fe982576e4aa7ec1224ffebf23c5ee4e892b91fef050840a83015aeddef1ebe92aaabe14a5b9d02
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Chorell, ErikAlmqvist, Fredrik

Search in DiVA

By author/editor
Chorell, ErikAlmqvist, Fredrik
By organisation
Department of Chemistry
In the same journal
PLoS ONE
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 82 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 645 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf